NEW YORK (TheStreet) -- CHANGE IN RATINGS
downgraded at MKM from Buy to Neutral. Loss of the CEO comes at a bad time.
( CBE) upgraded at Citigroup from Hold to Buy. Valuation call, as the company has solid, early-cycle exposure. $40 price target.
reinstated at Merrill/BofA with a Neutral rating. 2009 and 2010 EPS estimates set at $2.04 and $2.63, respectively. Price target set at $58.
downgraded at UBS. Rating lowered to Sell from Neutral. Maintains $10 price target and 2009 EPS estimates of -$0.85.
downgraded at Needham to Hold. Valuation call, as the stock is already pricing in some approvals in the clinical pipeline.
downgraded at Soleil from Buy to Hold. New $62 price target, as it will be difficult to achieve near-term earnings upside.
Las Vegas Sands
upgraded at Argus from Hold to Buy. $18 price target. Las Vegas and Macau should continue to stabilize.
rated new Outperform at Credit Suisse. $18 price target. Company should be an early-cycle beneficiary of an economic recovery.
downgraded at Citigroup from Hold to Sell. Valuation call, as CBE offers better value at current levels.
rated new Outperform at Barrington. $26 price target. Company has several outlets for growth and is positioned well within its industry.
downgraded at UBS. Rating lowered to Neutral from Buy. Maintains $24 price target and 2009 EPS estimates of -$3.30.
( SII) downgraded at FBR from Outperform to Market Perform. $38 price target. Estimates also cut, to reflect market share losses in Brazil.
upgraded at Goldman from Neutral to Buy. Stock was also added to the Conviction List, as fundamentals are improving and the company has potential catalysts ahead. $23 price target.
STOCK COMMENTS / EPS CHANGES
estimates lowered at Goldman through 2013. Company sold new shares and debt. Buy rating.
( ADCT) target, estimates slashed at Barclays. Price target to $8 from $9 on concerns about 2010 growth prospects. 2009 and 2010 EPS estimates lowered to $0.18 from $0.29 and to $0.50 from $0.63. Maintain Equal Weight rating.
target raised, estimates lowered at Thomas Weisel. 2009 and 2010 EPS estimates cut to $1.52 from $1.55 and to $1.57 from $1.65, respectively, following eBay's sale of Skype. Price target lifted to $22 from $19. Reiterate Market Weight rating.
target raised at FBR to $27. Stock remains attractive, following the Skype deal. Outperform rating.
target increased at UBS to $23. Now incorporating a DCF valuation. Neutral rating.
estimate raised at Barclays. Increased HOV 2009 EPS estimate to -$7.08 from -$7.56. Maintain 2010 EPS estimate at $3.40. Reiterate Underweight rating and $1.50 price target.
target boosted at Credit Suisse to $26. Pricing has been firm and the company is benefiting from alternative fuel credits. Overweight rating.
estimates lowered at Credit Suisse through 2011. Company is facing higher pulp prices, but still has an attractive dividend. Outperform rating and $66 price target.
target raised at UBS to $14.50. Stock can trade at 0.8 times trough book value, but maintain a cautious outlook. Neutral rating.
( LZ) numbers boosted at Keybanc through 2010. Company has strong pricing power. Buy rating and new $80 price target.
target raised at UBS to $18. Shifting to the 2010 earnings estimate, where double-digit earnings growth is possible. Neutral rating.
numbers boosted at Credit Suisse to $12. Estimates also changed, to reflect the CTX merger. Neutral rating.
target raised at Credit Suisse to $26. Pricing has remained strong. Outperform rating.
estimates raised at Deutsche Bank. 2009 EPS estimates raised to $0.25 from $0.17. Maintains Hold rating and $13 price target.
cut from Conviction List at Goldman. $32 price target. Stock has outperformed over the past year, and has limited upside potential. Buy rating.
This article was written by a staff member of TheStreet.com.